SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFN14A - Definitive proxy statement filed by non-management:
SEC Accession No. 0000899140-05-001021
Filing Date
2005-11-16
Accepted
2005-11-16 16:39:23
Documents
2
Period of Report
2005-11-16
Effectiveness Date
2005-11-16

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT t111605a.txt DEFN14A 2481
2 PRESS RELEASE t111505c.txt EX-1 7492
  Complete submission text file 0000899140-05-001021.txt   11991
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFN14A | Act: 34 | File No.: 000-20720 | Film No.: 051210239
SIC: 2834 Pharmaceutical Preparations

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFN14A